Table 1 Demographic and neuropathological data of human samples
Diagnosis | Case | Sex | Age (years) | PMD (hours) | Disease score | Reported concomitant misfolded protein pathologies* |
|---|---|---|---|---|---|---|
CTL | ||||||
1 | F | 86 | 5.7 | / | / | |
2 | F | 80 | 17.5 | / | / | |
3 | F | 89 | 23.6 | / | Some senile plaques and NFTs | |
4 | M | 89 | 32.2 | / | / | |
5 | M | 80 | 13.0 | / | Some senile plaques | |
6 | F | 83 | 35.7 | / | / | |
7 | F | 95 | 23.7 | / | / | |
8 | M | 85 | 26.7 | / | / | |
9 | M | 83 | 16.8 | / | / | |
10 | M | 89 | 31.9 | / | A1B1C1 | |
11 | F | 55 | 21.1 | / | / | |
DLB | ||||||
12 | M | 70 | 24.5 | Neo-cortical diffuse | Senile plaques and NFTs | |
13 | M | 89 | 17.0 | Limbic transitional | Mixed AD | |
14 | M | 75 | 21.0 | Neo-cortical | Senile plaques and NFTs | |
15 | M | 64 | 17.2 | Neo-cortical | Senile plaques and NFTs | |
16 | F | 83 | 17.7 | Neo-cortical | Senile plaques and NFTs | |
17 | M | 82 | 22.0 | Neo-cortical diffuse | / | |
18 | F | 81 | 8.6 | Neo-cortical diffuse | / | |
19 | F | 74 | 27.6 | Neo-cortical | A2B2C0 | |
20 | M | 91 | 85.0 | Neo-cortical diffuse | Braak III/IV | |
AD | ||||||
21 | M | 80 | 15.5 | Braak IV | / | |
22 | M | 82 | 11.5 | Braak IV | / | |
23 | M | 85 | 31.1 | A2B3C2 | / | |
24 | F | 83 | 25.0 | A2B3C2 | / | |
25 | M | 91 | 25.0 | A2B3C2 | / | |
26 | F | 96 | 26.5 | Braak IV/V | / | |
27 | M | 87 | 21.7 | A2B3C2 | / | |
28 | M | 90 | 26.1 | A3B2C3 | / | |
29 | F | 87 | 17.0 | A1B2C2 | / | |
30 | M | 90 | 32.0 | A2B2C3 | / | |